These results suggest that the extent of Fv-Fc interactions may vary from mAb to mAb, even within one subclass, since changing the CDR changes the antibodys properties, including propensity for PPIs
Injection quantities vary per individual purpose
Because independent long-term human trials are limited for the injectable options, unknown risks cannot be ruled out
consumers should verify pharmacies via the GPhC register and report illegal sales to the MHRA
These effects can include fatigue and weakness, numbness and tingling in the hands and feet, and memory loss and cognitive decline
What the Science Says The short answer: BPC-157 appears to be safe in animal models and anecdotal human use , but definitive safety conclusions for long-term human use have not yet been established